Solventum Corp
Uždarymo kaina
75.55 2.08
Apžvalga
Akcijų kainos pasikeitimas
24 val.
Min
73.68
Max
75.86
Pajamos | -50M 13M |
|---|---|
Pardavimai | 9M 2B |
P/E Sektoriaus vid. | 9.004 31.796 |
Pelnas, tenkantis vienai akcijai | 1.48 |
Pelno marža | 0.648 |
Darbuotojai | 20,584 |
EBITDA | -276M 213M |
Rekomendacijos | Pirkti |
|---|---|
12 mėnesių prognozė | +12.18% upside |
Kitas uždarbis | 2026-08-06 |
|---|
Rinkos kapitalizacija | 1B 13B |
|---|---|
Ankstesnė atidarymo kaina | 73.47 |
Ankstesnė uždarymo kaina | 75.55 |
Solventum Corp Grafikas
Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.
Apie bendrovę Solventum Corp
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.